Sürdürülebilir Kalkınma Amaçları
Bu dergideki yayınlar
1 →- Derleme MakaleAçık Erişim2021COVID-19 vaccine and immune response
Hintistan, Sevilay; Demirağ, Hatice
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; βCoV), the causative agent of coronavirus disease 2019 (COVID-19), causes severe lower respiratory tract infections and acute respiratory failure syndrome (ARDS). Deaths due to the ongoing COVID-19 pandemic for more than a year are still seen worldwide. Therefore, vaccine trials have gained importance. The discovery of the genome and protein structure of SARS-CoV-2 in a short time allowed the development of nucleic acid-based vaccines (mRNA and DNA vaccines), vector vaccines, inactivated virus vaccines, protein-based vaccines, virus-like particle vaccines, and live attenuated virus vaccines. Many companies, universities, and institutes around the world continue to develop effective vaccines against SARS-CoV-2. In this review, the structural features, classification, genome, and intracellular entry of SARS-CoV-2 coronaviruses, stimulation of the immune system and immunity, COVID-19 vaccine types, and the latest status of clinical trials of these vaccines have been reviewed.
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| creativeworkseries.issn | 2768-6655 | |
| dc.date.accessioned | 2026-10-22T10:22:57.550769792Z | |
| dc.date.available | 2026-10-22T10:22:57.550769792Z | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/gumushane/14650 | |
| dc.publisher | Open Exploration Publishing Inc | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.title | Exploration of Immunology | |
| dspace.entity.type | Journal |

